# EUCRATES BIOMEDICAL ACQU COR (EUCRU)

> Institutional ownership reported to the SEC as of Q1 2023, from Form 13F filings. Source: https://holderbook.com/stocks/EUCRU/

- Reporting holders: 4
- Reported value: $6.7M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Verition Fund Management LLC](https://holderbook.com/funds/1454027-verition-fund-management-llc/) | $4.1M | 397,603 | 0.1% | 9 |
| [Sio Capital Management, LLC](https://holderbook.com/funds/1482416-sio-capital-management-llc/) | $2.6M | 248,674 | 1.3% | 10 |
| [CLEAR STREET LLC](https://holderbook.com/funds/1708828-clear-street-llc/) | $28.4K | 2,740 | 0.0% | 2 |
| [DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)](https://holderbook.com/funds/1009258-deerfield-management-company-l-p-series-c/) | $10 | 1 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2023 | 4 | $6.7M |
| Q4 2022 | 6 | $6.5M |
| Q3 2022 | 11 | $15.4M |
| Q2 2022 | 15 | $16.9M |
| Q1 2022 | 18 | $18.4M |
| Q4 2021 | 14 | $27.1M |
| Q3 2021 | 17 | $41.2M |
| Q2 2021 | 18 | $43.5M |
| Q1 2021 | 23 | $50.9M |
| Q4 2020 | 37 | $90.4M |